Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    NCT01730768
Show Display Options
Rank Status Study
1 Completed A Study to Evaluate the Effects of Once Daily Doses of AQW051 on Cognition, in Stable Schizophrenia Patients
Condition: Schizophrenia
Interventions: Drug: AQW051;   Drug: Placebo

Indicates status has not been verified in more than two years